Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer
- David S. Ettinger
- , Robert Jotte
- , Paul Lorigan
- , Vicram Gupta
- , Lawrence Garbo
- , Carlos Alemany
- , Paul Conkling
- , David R. Spigel
- , Arkadiusz Z. Dudek
- , Chirag Shah
- , Ravi Salgia
- , Richard McNally
- , Markus F. Renschler
- , Jennifer W. Oliver
Research output: Contribution to journal › Article › peer-review
103
Link opens in a new tab
Scopus
citations